Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-07 17:17:06 - browse：24637

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： There’s a way to spot data fakery. All journals should be using it

WSS

Stanford president’s abrupt resignation sparks debate

There’s a way to spot data fakery. All journals should be using it

Stroke rates rising, especially in working

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

New research sheds light on how often breast cancer is overdiagnosed

Extensive review finds private equity owners jack up cost of care

knowledge

Wikipedia

hotspot

Virginia high school admissions case could be legal follow

Hormonal contraceptives don’t actually treat endometriosis

How one medical school became remarkably diverse

Why some fertility treatments produce more boy babies

The cancer drug shortage isn’t new — and neither are the solutions

There’s a way to spot data fakery. All journals should be using it

Cancer drug shortages should be causing more outrage

Lawsuit challenges CMS nursing home minimum staffing rule

BioMarin wins approval for gene therapy to treat hemophilia A

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

knowledge

Why some fertility treatments produce more boy babies

Judge denies Trump's request for new trial in E. Jean Carroll case

Why we need mandatory labeling of GMO products

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

Delta passengers in Vegas fall sick while waiting on flight in triple

Mystery swirls around US soldier who entered North Korea days ago, officials say

Wikipedia

hotspot

focus

entertainment